Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
Recruiting · NCT06397456 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Chicago
View the official record on ClinicalTrials.gov →Interventions studied
Blood pressure monitoringCommitment to ChangeCommunity-based education session, reinforcement for self-managementIn-Person Patient EducationText-based reinforcement for CKD self-managementText-based reinforcement for general health self-managementWritten Patient Education
What this trial is about
Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.
Who can take part
Age range
18 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients over the age of 18 and under 70
- Admitted to the University of Chicago inpatient general medicine service
- Likely hospital stay greater than 48 hours
- Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR\<45 during admission and from previous medical encounters)
- Self-identify as Black or African American
Exclusion criteria
- Non-English speaking
- Unable to communicate due to current medical status
- Unable to consent due to mental status
- Expected hospital stay less than 24 hour
- Current admission in ICU
Where it is running
2 locations listed across 1 US state.
- University of Chicago Medical Center - Chicago, Illinois, United States
- University of Chicago Medical Center - Chicago, Illinois, United States